Analysis of HCV Variants in the MAGELLAN-1 Part 1 Study: ABT-493 and ABT-530 Combination Therapy of Genotype 1-Infected Patients Who Had Failed Prior Direct Acting Antiviral-Containing Regimens

Ng Teresa; Pilot-Matias Tami; Tripathi Rakesh; Schnell Gretja; Reisch Thomas; Beyer Jill; Dekhtyar Tanya; Asatryan Armen; Mensa Federico; Kort Jens; Collins Christine

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Analysis of HCV Variants in the MAGELLAN-1 Part 1 Study: ABT-493 and ABT-530 Combination Therapy of Genotype 1-Infected Patients Who Had Failed Prior Direct Acting Antiviral-Containing Regimens

【24h】

Analysis of HCV Variants in the MAGELLAN-1 Part 1 Study: ABT-493 and ABT-530 Combination Therapy of Genotype 1-Infected Patients Who Had Failed Prior Direct Acting Antiviral-Containing Regimens

机译：Magellan-1第1部分的HCV变体分析：ABT-493和ABT-530组合治疗基因型1感染患者，其未发生含有含抗病毒方案的失败

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共2页
作者
Ng Teresa; Pilot-Matias Tami; Tripathi Rakesh; Schnell Gretja; Reisch Thomas; Beyer Jill; Dekhtyar Tanya; Asatryan Armen; Mensa Federico; Kort Jens; Collins Christine;
展开▼
作者单位

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

AbbVie N Chicago IL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Analysis of HCV Variants in the MAGELLAN-1 Part 1 Study: ABT-493 and ABT-530 Combination Therapy of Genotype 1-Infected Patients Who Had Failed Prior Direct Acting Antiviral-Containing Regimens [J] . Ng Teresa, Pilot-Matias Tami, Tripathi Rakesh, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Magellan-1第1部分的HCV变体分析：ABT-493和ABT-530组合治疗基因型1感染患者，其未发生含有含抗病毒方案的失败
2. Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection [J] . Lawitz Eric J., ORiordan William D., Asatryan Armen, Antimicrobial agents and chemotherapy. . 2016,第3期

机译：直接作用抗病毒药ABT-493和ABT-530联合三天单药治疗丙型肝炎病毒基因型1的有效抗病毒活性。
3. Safety and Efficacy of the Fixed-Dose Combination Regimen of MK-3682/Grazoprevir/MK-8408 in Cirrhotic or Non-cirrhotic Patients with Chronic HCV GT1 Infection who Previously Failed a Direct-acting Antiviral Regimen (C-SURGE) [J] . Wyles David L., Wedemeyer Heiner, Reddy K. Rajender, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：MK-3682 / GrazoPrevir / MK-8408在肝硬化或非肝硬化患者中的固定剂量组合方案的安全性和有效性慢性HCV GT1感染患者，慢性HCV GT1感染患者以前失败的直接作用抗病毒方案（C-SHORGE）
4. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
5. Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection [O] . Eric J. Lawitz, William D. ORiordan, Armen Asatryan, 2016

机译：直接作用抗病毒药ABT-493和ABT-530联合三天单药治疗丙型肝炎病毒基因型1的有效抗病毒活性。
6. High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis [O] . Edward Gane, Fred Poordad, Stanley Wang, 2016

机译：HCV基因型1或3感染患者ABT-493和ABT-530治疗的高疗效和补偿肝硬化
7. Phase I/II Study of Combination Neoadjuvant Hormone Therapy and Weekly OGX-011 (Clusterin Antisense Oligonulceotide) Prior to Radical Prostatectomy in Patients with Localized Prostate Cancer [R] . Chi, K. N. 2008

机译：I / II期研究联合新辅助激素治疗和每周OGX-011（Clusterin反义寡核苷酸）前局部前列腺癌根治性前列腺切除术

Analysis of HCV Variants in the MAGELLAN-1 Part 1 Study: ABT-493 and ABT-530 Combination Therapy of Genotype 1-Infected Patients Who Had Failed Prior Direct Acting Antiviral-Containing Regimens

著录项

相似文献

相关主题

期刊订阅